We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2526
GBank Financial Holdings
GBFH
$220M
| $2.34M | ﹤0.01% |
+77,245
| New | +$2.25M |
2026 Q2
0 quarters
|
|
2527
Viridian Therapeutics
VRDN
$2.79B
| $2.34M | ﹤0.01% |
127,301
+107,093
| +530% | +$1.73M |
2026 Q1
1 quarter
|
|
2528
Victory Capital Holdings
VCTR
$6.8B
| $2.34M | ﹤0.01% |
27,780
-4,457
| -14% | -$359K |
2020 Q2
24 quarters
|
|
2529
Gold.com Inc
GOLD
$1.11B
| $2.34M | ﹤0.01% |
56,117
-10,332
| -16% | -$444K |
2021 Q1
21 quarters
|
|
2530
Vanguard S&P 500 Value ETF
VOOV
$6.88B
| $2.33M | ﹤0.01% |
10,637
-6,528
| -38% | -$1.41M |
2025 Q4
2 quarters
|
|
2531
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.13B
| $2.33M | ﹤0.01% |
52,849
+25,811
| +95% | +$1.13M |
2025 Q2
4 quarters
|
|
2532
Globalstar
GSAT
$10.7B
| $2.32M | ﹤0.01% |
28,596
+5,551
| +24% | +$447K |
2025 Q3
3 quarters
|
|
2533
Atrium Therapeutics
RNA
$141M
| $2.32M | ﹤0.01% |
+172,235
| New | +$2.25M |
2026 Q2
0 quarters
|
|
2534
MaxCyte
MXCT
$164M
| $2.32M | ﹤0.01% |
1,882,776
+661,594
| +54% | +$659K |
2023 Q3
11 quarters
|
|
2535
Veeco
VECO
$2.38B
| $2.31M | ﹤0.01% |
30,462
-18,861
| -38% | -$1.08M |
2019 Q3
27 quarters
|
|
2536
Rigetti Computing
RGTI
$3.75B
| $2.3M | ﹤0.01% |
119,301
+2,794
| +2% | +$54K |
2024 Q3
7 quarters
|
|
2537
Tilray
TLRY
$374M
| $2.3M | ﹤0.01% |
512,599
+65,011
| +15% | +$372K |
2024 Q3
7 quarters
|
|
2538
Hinge Health
HNGE
$9.22B
| $2.3M | ﹤0.01% |
+27,706
| New | +$1.5M |
2026 Q2
0 quarters
|
|
2539
Bel Fuse Inc Class B
BELFB
$3.41B
| $2.29M | ﹤0.01% |
6,885
+321
| +5% | +$86.7K |
2023 Q4
10 quarters
|
|
2540
Glaukos
GKOS
$14.1B
| $2.29M | ﹤0.01% |
16,401
+2,075
| +14% | +$263K |
2023 Q4
10 quarters
|
|
2541
Eledon Pharmaceuticals
ELDN
$225M
| $2.29M | ﹤0.01% |
581,028
+408,611
| +237% | +$1.49M |
2025 Q4
2 quarters
|
|
2542
iShares S&P Small-Cap 600 Value ETF
IJS
$7.72B
| $2.29M | ﹤0.01% |
16,740
+2,895
| +21% | +$373K |
2024 Q4
6 quarters
|
|
2543
Covenant Logistics
CVLG
$785M
| $2.29M | ﹤0.01% |
51,756
-16,075
| -24% | -$586K |
2017 Q2
36 quarters
|
|
2544
The GEO Group
GEO
$3.75B
| $2.28M | ﹤0.01% |
77,026
+17,097
| +29% | +$388K |
2022 Q3
15 quarters
|
|
2545
Vanguard FTSE Pacific ETF
VPL
$8.43B
| $2.27M | ﹤0.01% |
19,660
+7,918
| +67% | +$875K |
2025 Q2
4 quarters
|
|
2546
Farmers & Merchants Bancorp
FMAO
$501M
| $2.27M | ﹤0.01% |
74,087
+59,169
| +397% | +$1.63M |
2025 Q3
3 quarters
|
|
2547
Farmland Partners
FPI
$354M
| $2.26M | ﹤0.01% |
233,167
+98,826
| +74% | +$1.05M |
2025 Q2
4 quarters
|
|
2548
ACNB Corp
ACNB
$665M
| $2.25M | ﹤0.01% |
37,944
+28,659
| +309% | +$1.53M |
2025 Q2
4 quarters
|
|
2549
Wynn Resorts
WYNN
$7.69B
| $2.25M | ﹤0.01% |
23,133
-78,199
| -77% | -$8.07M |
2023 Q1
13 quarters
|
|
2550
Tanger
SKT
$4.22B
| $2.24M | ﹤0.01% |
56,844
+5,225
| +10% | +$194K |
2021 Q2
20 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.